Answer
Sunitinib can lower blood glucose, sometimes causing symptoms and loss of consciousness requiring hospitalisation; treatment should be temporarily interrupted for symptomatic hypoglycaemia, and diabetic patients need regular glucose checks to assess whether diabetes medicine doses require adjustment.
Sources for this answer
- Sunitinib 12.5mg Hard CapsulesTeva UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked